Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-controlled versus physician-administered propofol for emergency department procedural sedation
ACTRN12607000548437Phase 4Recruiting
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol in procedural sedation and analgesia (PSA) (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: Total propofol dose. Started Dec 2007; status: recruiting.
02
Drugs
propofol
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ACTRN12607000548437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000548437.